CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors
Portfolio Pulse from
CalciMedica Inc. has appointed Dr. Alan Glicklich to its Board of Directors. The company is focused on developing CRAC channel inhibition therapies for inflammatory and immunologic illnesses.
January 14, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CalciMedica Inc. has appointed Dr. Alan Glicklich to its Board of Directors, potentially strengthening its leadership and strategic direction in developing CRAC channel therapies.
The appointment of Dr. Alan Glicklich to the Board of Directors could bring valuable expertise and leadership to CalciMedica, potentially positively impacting its strategic direction and investor confidence in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100